News about Market

UK and EU Drugs Agency Sign Pact to Strengthen Response to Emerging Drug Threats

The UK government and the European Union Drugs Agency (EUDA) have signed a new cooperation agreement to enhance intelligence sharing on emerging drug threats, strengthen public health protection and improve coordinated action against illicit drug trafficking across Europe.

Market | 15/07/2026 | By News Bureau

AstraZeneca Enters into Global License Agreement with with Dizal Pharmaceutical for Zegfrovy

AstraZeneca has entered a global licensing agreement with Dizal Pharmaceutical for Zegfrovy, expanding its EGFR-targeted lung cancer portfolio.

Market | 15/07/2026 | By News Bureau

Sun Pharma Receives Approval to Manufacture and Market Generic Semaglutide in South Africa

Sun Pharma has received approval to manufacture and market generic semaglutide in South Africa, available as a once-weekly pre-filled multi-dose injectable pen in 2 strengths.

Market | 15/07/2026 | By News Bureau

NATCO Pharma Acquires Additional 13.25 Percent Stake in Adcock Ingram

NATCO Pharma has completed the acquisition of an additional 13.25 percent stake in South Africa's Adcock Ingram, strengthening its strategic investment in the pharmaceutical company.

Market | 15/07/2026 | By News Bureau

Emcure Takes Full Ownership of Gennova, Strengthens Focus on Biologics and Biosimilars

Emcure Pharmaceuticals has acquired the remaining minority stake in Gennova Biopharmaceuticals, making it a wholly owned subsidiary while appointing Samit Mehta to lead the company’s next phase of growth in biologics and biosimilars.

Market | 14/07/2026 | By News Bureau

Santhera Expands Agamree Distribution Partnership with Biomedica Across Five Additional Markets

Santhera Pharmaceuticals has expanded its exclusive distribution partnership with Biomedica to include Georgia, Kazakhstan, Belarus, Azerbaijan and Uzbekistan, extending access to Agamree (vamorolone) for patients with Duchenne muscular dystrophy across additional underserved markets.

Market | 14/07/2026 | By News Bureau

Torrent Pharma Recalls Select Semalix Injection Batches Following API-Related Quality Issue

Torrent Pharmaceuticals has initiated a recall of select batches of Semalix Injection 2 mg and 4 mg after certain semaglutide batches failed quality specifications due to an API-related issue.

Market | 10/07/2026 | By News Bureau

Novo Nordisk Brings World's First Once-Weekly Basal Insulin Awiqli to India

Novo Nordisk India has launched Awiqli, the world's first once-weekly basal insulin, offering adults with diabetes a more convenient treatment option with fewer injections.

Market | 10/07/2026 | By News Bureau |  148

Evonik Invests USD 100 Million to Expand US Drug Manufacturing

Evonik is investing USD 100 million to upgrade its US drug substance Contract Development and Manufacturing (CDMO) facility, expanding manufacturing capacity to meet growing demand for US-based pharmaceutical outsourcing.

Market | 10/07/2026 | By News Bureau

UK Life Sciences Attracts Investment to Create Jobs and Faster Patient Treatments

The UK life sciences sector has attracted over £3 billion in public-private investment in the past year, accelerating innovation, creating jobs, and improving patient access to new treatments.

Market | 10/07/2026 | By News Bureau